STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #118 by analyst upside · 2026-09-16
PAVM
PAVmed Inc.
Healthcare · Market Cap $39M · P/E 0x
ANALYST PRICE TARGET
+831.1%
implied upside to consensus target
Current Price $3.92
Consensus Target $36.5
Bull Target $57.0
Bear Target $16.0
Analysts Covering 2
ANALYST CONSENSUS - STRONG BUY
Strong Buy
1
Buy
1
Hold
0
Sell
0
52-Week Low $3.7
52-Week High $28.44
YTD Return -46.5%
FUNDAMENTALS
Market Cap $39M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-15.21
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $0M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $3.7
52-Week High $28.44
Current Price $3.92
Bear Target $16.0
Bull Target $57.0
● Now $3.92 ● Target $36.5
TRADING DATA
Avg Volume 31K
YTD Return -46.5%
Analyst Count 2
Consensus Strong Buy
Upside to Target +831.1%
Last Updated 2026-09-16

ANALYST SUMMARY

PAVmed Inc. (PAVM) is currently trading at $3.92 with a Wall Street consensus price target of $36.5, implying potential upside of 831.1% over the next 12 months. 2 analysts currently cover PAVM, with a consensus rating of Strong Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $57.0, while the most cautious has a target of $16.0.

PAVM operates in the Healthcare sector with a market capitalisation of $39M. The stock is down 46.5% year-to-date and is currently trading near the lower end of its 52-week range of $3.7 – $28.44.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for PAVM, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Ascendiant Capital - Reiterated
Buy → Buy 2026-08-27 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2026-06-08 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2026-04-09 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-12-10 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-10-06 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-06-06 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-04-21 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2024-12-09 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
35
out of 100
Coverage depth
8/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →